n(6)-carboxymethyllysine has been researched along with Genetic Predisposition in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aglago, EK; Aleksandrova, K; Amiano, P; Bueno-de-Mesquita, B; Colorado-Yohar, SM; Dahm, CC; Fedirko, V; Freisling, H; Gram, IT; Gunter, MJ; Gurrea, AB; Heath, AK; Hughes, DJ; Jakszyn, P; Jenab, M; Jiao, L; Johnson, T; Katzke, V; Macciotta, A; Masala, G; Mayén, AL; Olsen, A; Perez-Cornago, A; Sánchez, MJ; Sandanger, T; Schalkwijk, CG; Schulze, MB; Sieri, S; Simeon, V; Skeie, G; Tjønneland, A; Tumino, R; Weiderpass, E | 1 |
1 other study(ies) available for n(6)-carboxymethyllysine and Genetic Predisposition
| Article | Year |
|---|---|
Plasma concentrations of advanced glycation end-products and colorectal cancer risk in the EPIC study.
Topics: Adult; Aged; Chromatography, Liquid; Cohort Studies; Colorectal Neoplasms; Female; Genetic Association Studies; Genetic Predisposition to Disease; Glycation End Products, Advanced; Humans; Imidazoles; Lysine; Male; Middle Aged; Odds Ratio; Ornithine; Tandem Mass Spectrometry | 2021 |